Used in bone metabolism research to quantify levels of procollagen type I N-terminal propeptide (P1NP), a biomarker for bone formation. The ELISA kit enables researchers to assess osteoblastic activity in serum or plasma samples, making it valuable in studies related to osteoporosis, fracture risk, and response to anti-osteoporotic therapies. It is widely used in preclinical and clinical research settings to monitor bone turnover and evaluate the effectiveness of treatments affecting bone synthesis.